based on findings from the MIRACLE-AF trial presented at ESC Congress 2024 in London. The study randomly assigned 1,039 adults with AFib from 30 villages in rural China to receive either village ...
Early treatment with Ubrogepant significantly reduces migraine-related disability, allowing individuals to function normally soon after taking the drug, as demonstrated in a study with over 500 ...